Lyell Immunopharma announced new clinical data Tuesday from a Phase I/II trial of its dual-targeted CD19/CD20 CAR T-cell therapy for relapsed or refractory large B-cell lymphoma. The company ...

Some cancers and chronic inflammatory diseases are treated with immunotherapies. These stimulate the patient's immune system ...

Surbhi Sidana, MD, MBBS, director of the Myeloma Disease Focused Group at Stanford University, provides a reintroduction to ...

Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer ...

Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...

This valuable study presents a novel approach to enhance the therapeutic potential of mesenchymal stromal cells (MSCs) by genetically modifying their glycogen synthesis pathway, resulting in increased ...

Major depressive disorder (MDD) is a mental health condition that negatively affects the mood of a person and causes a loss ...

Announcing a new article publication for Zoonoses journal. Because varicella zoster virus (VZV) infections are continually ...

Influenza virions can take a variety of shapes, from the classic spherical or kidney bean morphology found in most ...

CPGs. Their model shows that cell-type-specific connectivity and a dominant inhibitory drive could underlie rhythm generation. Excitatory input could act to enhance the frequency range of these ...

Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for ...

Cutaneous T-cell lymphoma is a type of cancer. It starts in blood cells called T-lymphocytes. These are white blood cells that are part of your immune system. They normally fight infection in the body ...